MDL-001 as a Next-Generation HCV Thumb-1 Inhibitor with Clinical-Stage Safety
Events
Join us at The Liver Meeting on Monday, November 10, 2025 (11:00 AM – 12:30 PM ET).
Patrick ONeill
Head of Partnerships & Investor Relations
Dr. David (Davey) Smith will deliver the oral presentation titled “MDL-001 as a Next-Generation HCV Thumb-1 Inhibitor with Clinical-Stage Safety” at The Liver Meeting hosted by American Association for the Study of Liver Diseases (AASLD) in Washington, D.C., on Monday, November 10, 2025, from 11:00 AM to 12:30 PM ET.
Join us at The Liver Meeting on Monday, November 10, 2025 (11:00 AM – 12:30 PM ET).
